Koren-Michowitz, M., Gery, S., Tabayashi, T., Lin, D., Alvarez, R., Nagler, A., & Koeffler, H. P. (2013). SH2B3 (LNK) mutations from Myeloproliferative Neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F.
Citação norma ChicagoKoren-Michowitz, Maya, Sigal Gery, Takayuki Tabayashi, Dechen Lin, Rocio Alvarez, Arnon Nagler, and H. Phillip Koeffler. SH2B3 (LNK) Mutations From Myeloproliferative Neoplasms Patients Have Mild Loss of Function against Wild Type JAK2 and JAK2 V617F. 2013.
ציטוט MLAKoren-Michowitz, Maya, et al. SH2B3 (LNK) Mutations From Myeloproliferative Neoplasms Patients Have Mild Loss of Function against Wild Type JAK2 and JAK2 V617F. 2013.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.